Participation of FLIP, RIP and Bcl-xL in Fas-mediated T-cell death

Scandinavian Journal of Immunology

Volumn 66, Issue 4, 2007, Pages 410-421

  Djerbi, M ^a   Malinowski, M M ^b   Yagita, H ^c   Zhivotovsky, B ^d   Grandien, A ^b  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c JUNTENDO UNIVERSITY   (Japan)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; FAS ANTIGEN; FLICE INHIBITORY PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BCL XL; RECEPTOR INTERACTING PROTEIN 140;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DEATH; CELL PROTECTION; FEMALE; GENE TRANSFER; HEMATOPOIETIC STEM CELL; LYMPHOPROLIFERATIVE DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; THYMUS DISEASE;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; BCL-X PROTEIN; BLOTTING, WESTERN; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASES; CD4-POSITIVE T-LYMPHOCYTES; ENZYME INHIBITORS; FEMALE; FLOW CYTOMETRY; MICE; MICE, INBRED DBA; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TRANSDUCTION, GENETIC;

EID: 34548573432     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2007.01957.x     Document Type: Article

References (43)

1. Nagata S, Suda T. Fas and Fas ligand: lpr and gld mutations. Immunol Today 1995 16 : 39 43.
2. Cohen PL, Eisenberg RA. lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol 1991 9 : 243 69.
3. Zheng L, Fisher G, Miller RE, Peschon J, Lynch DH, Lenardo MJ. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 1995 377 : 348 51.
4. Martinez-Lorenzo MJ, Alava MA, Gamen S et al. Involvement of APO2 ligand/TRAIL in activation-induced death of Jurkat and human peripheral blood T cells. Eur J Immunol 1998 28 : 2714 25.
5. Rieux-Laucat F, Le Deist F, Fischer A. Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways. Cell Death Differ 2003 10 : 124 33.
6. Cretney E, Uldrich AP, Berzins SP, Strasser A, Godfrey DI, Smyth MJ. Normal thymocyte negative selection in TRAIL-deficient mice. J Exp Med 2003 198 : 491 6.
7. Lamhamedi-Cherradi SE, Zheng SJ, Maguschak KA, Peschon J, Chen YH. Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL-/- mice. Nat Immunol 2003 4 : 255 60.
8. Schulze-Osthoff K, Ferrari D, Los M, Wesselborg S, Peter ME. Apoptosis signaling by death receptors. Eur J Biochem 1998 254 : 439 59.
9. Krueger A, Baumann S, Krammer PH, Kirchhoff S. FLICE-inhibitory proteins: regulators of death receptor-mediated apoptosis. Mol Cell Biol 2001 21 : 8247 54.
10. Scaffidi C, Fulda S, Srinivasan A et al. Two CD95 (APO-1/Fas) signaling pathways. EMBO J 1998 17 : 1675 87.
11. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998 94 : 481 90.
12. Li H, Zhu H, Xu CJ, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998 94 : 491 501.
13. Adams JM, Cory S. Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci 2001 26 : 61 6.
14. Scaffidi C, Schmitz I, Krammer PH, Peter ME. The role of c-FLIP in modulation of CD95-induced apoptosis. J Biol Chem 1999 274 : 1541 8.
15. Holler N, Zaru R, Micheau O et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol 2000 1 : 489 95.
16. Kawahara A, Ohsawa Y, Matsumura H, Uchiyama Y, Nagata S. Caspase-independent cell killing by Fas-associated protein with death domain. J Cell Biol 1998 143 : 1353 60.
17. Matsumura H, Shimizu Y, Ohsawa Y, Kawahara A, Uchiyama Y, Nagata S. Necrotic death pathway in Fas receptor signaling. J Cell Biol 2000 151 : 1247 56.
18. Vonarbourg C, Stolzenberg MC, Holzelova E, Fischer A, Deist FL, Rieux-Laucat F. Differential sensitivity of Jurkat and primary T cells to caspase-independent cell death triggered upon Fas stimulation. Eur J Immunol 2002 32 : 2376 84.
19. Ahmad M, Srinivasula SM, Wang L et al. CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/tumor necrosis factor receptor-interacting protein RIP. Cancer Res 1997 57 : 615 9.
20. Duan H, Dixit VM. RAIDD is a new 'death' adaptor molecule. Nature 1997 385 : 86 9.
21. Droin N, Bichat F, Rebe C et al. Involvement of caspase-2 long isoform in Fas-mediated cell death of human leukemic cells. Blood 2001 97 : 1835 44.
22. Djerbi M, Darreh-Shori T, Zhivotovsky B, Grandien A. Characterization of the human FLICE-inhibitory protein locus and comparison of the anti-apoptotic activity of four different FLIP isoforms. Scand J Immunol 2001 54 : 180 9.
23. Nyakeriga AM, Djerbi M, Malinowksi MM, Grandien A. Simultaneous expression and detection of multiple retroviral constructs in haematopoietic cells after bone marrow transplantation. Scand J Immunol 2005 61 : 545 50.
24. Karasuyama H, Melchers F. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur J Immunol 1988 18 : 97 104.
25. Djerbi M, Screpanti V, Catrina AI, Bogen B, Biberfeld P, Grandien A. The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors. J Exp Med 1999 190 : 1025 32.
26. Steff AM, Fortin M, Arguin C, Hugo P. Detection of a decrease in green fluorescent protein fluorescence for the monitoring of cell death: an assay amenable to high-throughput screening technologies. Cytometry 2001 45 : 237 43.
27. Green DR, Droin N, Pinkoski M. Activation-induced cell death in T cells. Immunol Rev 2003 193 : 70 81.
28. Chao DT, Linette GP, Boise LH, White LS, Thompson CB, Korsmeyer SJ. Bcl-XL and Bcl-2 repress a common pathway of cell death. J Exp Med 1995 182 : 821 8.
29. Lens SM, Kataoka T, Fortner KA et al. The caspase 8 inhibitor c-FLIP(L) modulates T-cell receptor-induced proliferation but not activation-induced cell death of lymphocytes. Mol Cell Biol 2002 22 : 5419 33.
30. Hao Z, Hampel B, Yagita H, Rajewsky K. T cell-specific ablation of Fas leads to Fas ligand-mediated lymphocyte depletion and inflammatory pulmonary fibrosis. J Exp Med 2004 199 : 1355 65.
31. Chun HJ, Zheng L, Ahmad M et al. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 2002 419 : 395 9.
32. Newton K, Harris AW, Bath ML, Smith KG, Strasser A. A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. Embo J 1998 17 : 706 18.
33. Salmena L, Lemmers B, Hakem A et al. Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev 2003 17 : 883 95.
34. Walsh CM, Wen BG, Chinnaiyan AM, O'Rourke K, Dixit VM, Hedrick SM. A role for FADD in T cell activation and development. Immunity 1998 8 : 439 49.
35. Djerbi M, Abdul-Majid KB, Abedi-Valugerdi M, Olsson T, Harris RA, Grandien A. Expression of the long form of human FLIP by retroviral gene transfer of hemopoietic stem cells exacerbates experimental autoimmune encephalomyelitis. J Immunol 2003 170 : 2064 73.
36. Refaeli Y, Van Parijs L, London CA, Tschopp J, Abbas AK. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity 1998 8 : 615 23.
37. Van Parijs L, Refaeli Y, Abbas AK, Baltimore D. Autoimmunity as a consequence of retrovirus-mediated expression of C- FLIP in lymphocytes. Immunity 1999 11 : 763 70.
38. L. Proc Natl Acad Sci USA 1999 96 : 14871 6.
39. de la Coste A, Fabre M, McDonell N et al. Differential protective effects of Bcl-xL and Bcl-2 on apoptotic liver injury in transgenic mice. Am J Physiol 1999 277 : G702 8.
40. Lacronique V, Mignon A, Fabre M et al. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nat Med 1996 2 : 80 6.
41. Rodriguez I, Matsuura K, Khatib K, Reed JC, Nagata S, Vassalli P. A bcl-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody injection. J Exp Med 1996 183 : 1031 6.
42. Strasser A, Harris AW, Huang DC, Krammer PH, Cory S. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. Embo J 1995 14 : 6136 47.
43. Yin XM, Wang K, Gross A et al. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature 1999 400 : 886 91.